DUTCH Weight Control in Atrial Fibrillation Study

Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation

NCT06433479 ·Status: COMPLETED ·Phase: NA

First In Human Study of the Doraya Catheter for the Treatment of AHF Patients

NCT03234647 ·Status: COMPLETED ·Phase: NA

Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients

NCT03271879 ·Status: UNKNOWN ·Phase: PHASE4

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS

NCT00232297 ·Status: COMPLETED ·Phase: PHASE2

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain

NCT03285373 ·Status: COMPLETED

Odiparcil QT Definitive Study

NCT00437242 ·Status: TERMINATED ·Phase: PHASE1

Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response

NCT05691959 ·Status: UNKNOWN ·Phase: PHASE2

A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects.

NCT02911870 ·Status: COMPLETED ·Phase: PHASE1

Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation

NCT02623049 ·Status: UNKNOWN

Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

NCT02744339 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Safety and Effectiveness on Oral Anticoagulants

NCT03765242 ·Status: COMPLETED

A Study of CLR325 in Chronic Stable Heart Failure Patients.

NCT02696967 ·Status: COMPLETED ·Phase: PHASE2

Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction

NCT02053493 ·Status: COMPLETED ·Phase: PHASE2

A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function

NCT03657446 ·Status: COMPLETED ·Phase: PHASE1

Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

NCT01065051 ·Status: TERMINATED ·Phase: PHASE2

Echocardiography During Ajmaline Test

NCT03491475 ·Status: UNKNOWN

Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation

NCT04792190 ·Status: COMPLETED ·Phase: PHASE4

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

NCT01258387 ·Status: COMPLETED ·Phase: PHASE1

Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation

NCT06759909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Survey on Belgian Patients Suffering From Irregular Heartbeat and Starting Treatment With a Drug to Prevent Blood Clots in Blood Vessels and the Heart. This Study is Also Called BELANCOS.

NCT04183270 ·Status: COMPLETED

Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine

NCT03387605 ·Status: UNKNOWN ·Phase: PHASE4

Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction

NCT04475042 ·Status: UNKNOWN ·Phase: PHASE2

Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

NCT01135017 ·Status: TERMINATED ·Phase: PHASE4

Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction

NCT05350969 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate

NCT06772246 ·Status: COMPLETED ·Phase: PHASE1